Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's lamotrigine 25
mg tablets to GlaxoSmithKline's (GSK) Lamictal® 25 mg tablets following a single, oral 50 mg
(2 x 25 mg) dose administration under fed conditions.